Stem cells are particularly useful in the regeneration of tissues that have poor potential for repair. One such tissue is cartilage, which normally does not regenerate after birth. The cartilage found within joints is called articular cartilage, which wears out over time and has a short lifespan.
Fortunately, stem cells can help with OA in a number of ways. Mesenchymal stem cells (MSCs), which are known to orchestrate the body’s natural healing, have successfully been used to restore degenerated cartilage within joints. This treatment can bypass the need for painful and invasive joint replacement surgeries, while significantly reducing recovery times.
MSCs also have anti-inflammatory properties, and naturally migrate to sites of inflammation in the body. There, MSCs suppress the immune response to bring down inflammation. In this way, mesenchymal stem cell therapy can also alleviate pain in OA. In fact, in early-phase clinical trials, administration of MSCs was linked to pain reduction and cartilage protection.
Our protocol aims to reduce the overall levels of chronic low-grade inflammation in the body. The effects are expected to last for a very long time.
Stem cells are uniquely and intrinsically able to migrate to sites of damage and inflammation in the body. Studies have shown that stem cells are able to orchestrate the repair and regeneration of deteriorated tissues, as well as modulate the immune system, to promote better health.
Depending on the ailment or the patient’s initial condition, the benefits of stem cell therapy can include a reduction in harmful symptoms, the slowing of the progression of the disease, and an overall increase in quality of life.
